The National Cancer Institute estimates that more than 150,000 people will receive a colorectal cancer diagnosis in 2025, and factors like gender, age, and family health history can increase your risk ...

Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...

Colorectal cancer (CRC) is the second most common cause of cancer death in the United States and disproportionally impacts people who receive care in under-resourced settings.

Patients with a specific type of bowel cancer who were treated with a short course of immunotherapy before surgery instead of ...

Researchers are rethinking how we target bowel cancer growth pathways, using patient-derived organoids to identify whether hyperactivating growth genes, rather than inhibiting them, improves outcomes.

Inflammatory Bowel Disease (IBD) is a chronic disease of inflammation along the digestive tract. There are two forms of IBD, including Crohn’s disease and ulcerative colitis. Symptoms include ...

Scientists have pinpointed a “Big Bang” moment in bowel cancer—when cells first evade the immune system. This early immune escape locks in how the cancer will behave as it grows. The discovery could ...